Back to Pathway Library

Oncology

Prostate Cancer

Avoid unnecessary appointments, by keeping patients on track

Prostate cancer is reported as the second most common cancer in men, impacting the life of 1 in every 8 men. After local treatment, prostate-specific antigen (PSA) monitoring is widely recognized as the gold-standard for follow-up. However, nowadays, this follow-up depends on a physical appointment with a physician.

What does Hilly do?

  1. Gathers clinical information;
  2. Evaluates signs/symptoms;
  3. Automates requests for PSA measurement according to trigger symptoms, previous results, progression and follow-up duration.

Key advantages

  • Reduce the time spent on repetitive and low-value tasks;
  • Avoid unnecessary appointments;
  • Faster detection of red flags signs/symptoms of an imminent decompensation;
  • Optimize the use of resources, reduce costs and increase capacity.

References

  • EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2022 Update. https://uroweb.org/guidelines/prostate-cancer
  • Mohler JL, Antonarakis ES. NCCN Guidelines Updates: Management of Prostate Cancer. J Natl Compr Canc Netw. 2019;17(5.5):583-586. doi:10.6004/jnccn.2019.5011

Move towards Patient-Centered care with UpHill

Talk to Sales